Login / Signup

Neuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcome.

Cody PlastererShirng-Wern TsaihAmy R PeckInna ChervonevaCaitlin O'MearaYunguang SunAngela LemkeDana MurphyJennifer SmithSophia RanAlbert J KovatichJeffrey A HookeCraig D ShriverHai HuEdith P MitchellCarmen BergomAmit JoshiPaul AuerJeremy ProkopHallgeir RuiMichael J Flister
Published in: Breast cancer research and treatment (2019)
Collectively, these data implicate NNAT as a novel mediator of cell proliferation and migration, which correlates with decreased tumorigenic potential and prolonged patient survival.
Keyphrases
  • estrogen receptor
  • positive breast cancer
  • single cell
  • risk factors
  • case report
  • electronic health record
  • cell therapy
  • big data
  • bone marrow
  • human health
  • machine learning
  • artificial intelligence
  • deep learning